Reaction
Solar Dermatitis reporting signals
As of the last recalculation, Solar Dermatitis appears in 268 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is VEMURAFENIB (PRR 139.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Vemurafenib | 20 | 139.6 | 139.8 |
| Rucaparib | 7 | 63.2 | 63.2 |
| Pirfenidone | 27 | 57.2 | 57.2 |